A retrospective chart review of drug treatment patterns and clinical outcomes among patients with metastatic or recurrent soft tissue sarcoma refractory to one or more prior chemotherapy treatments

References

Page 1

	Year	Citations
The National Comprehensive Cancer Network William T. McGivney Cancer Cancer ManagementPathologyCancer RegistrationCancer PatientsCancer Education	1998	16.9K
SEER Cancer Statistics Review, 1975-2003 Lynn A. G. Ries, D. Harkins, Martin Krapcho, ScholarWorks - Georgia State University (Georgia State University)	2006	11.5K
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial Winette T.A. van der Graaf, Jean‐Yves Blay, Sant P. Chawla, The Lancet Metastatic Soft-tissue SarcomaPlacebo-controlled Phase 3MedicineMetronomic TherapyClinical Trials	2012	2K
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo G. Casali, N. Abecassis, Sebastian Bauer, Annals of Oncology	2018	1.6K
Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002 Robert G. Maki, J. Kyle Wathen, Shreyaskumar Patel, Journal of Clinical Oncology	2007	719
Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas Jean‐Michel Coindre, Philippe Terrier, Louis Guillou, Cancer	2001	713
Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing Françoise Ducimetière, A. Lurkin, Dominique Ranchère‐Vince, PLoS ONE	2011	538
Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules George D. Demetri, Sant P. Chawla, Margaret von Mehren, Journal of Clinical Oncology	2009	524
Trends in survival for patients with metastatic soft‐tissue sarcoma Antoîne Italiano, Simone Mathoulin‐Pélissier, Axel Le Cesne, Cancer	2010	300
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients A.T. van Oosterom, H.T. Mouridsen, Ole S. Nielsen, European Journal of Cancer Surgical OncologyBone Sarcoma GroupMedicineMetronomic TherapyPathology	2002	164

Page 1